Clinic Study of 18F-Al-NOTA-MATBBN in Cancer Diagnostics
The purpose of this study is to determine whether 18F-Al-NOTA-MATBBN is safety and effective for cancer diagnosis.
Breast Neoplasms|Prostatic Neoplasms
DRUG: 18F-Al-NOTA-MATBBN PET/CT|DEVICE: PET/CT
Standardized uptake value of 18F-Al-NOTA-MATBBN in malignant lesions, The semiquantitative analysis will be performed by the same person for all the cases, and the standardized uptake value (SUV) of the tracer in malignant lesions will be measured., 1 day
Adverse events collection, Adverse events within 1 week after the injection and scanning of patients and patients will be followed and assessed., 1 week
Observe radiation dose to healthy volunteers and patients; the correlation between integrin level and tumor/metastases uptake.